Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis  Thoetchai (Bee) Peeraphatdit, Douglas A. Simonetto, Vijay H. Shah  Journal of Hepatology  Volume 69, Issue 2, Pages 275-277 (August 2018) DOI: 10.1016/j.jhep.2018.05.012 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Bile acid and non-bile acid treatment targets of non-alcoholic hepatitis and cholestasis that can be opportunities in alcoholic hepatitis. ASK1, apoptosis signal-regulating kinase 1, C4, 7α-Hydroxy-4-cholesten-3-one, CCR2/5, C-C chemokine receptor type 2/5, FGF, fibroblast growth factor, FXR, farnesoid X receptor, PPAR, peroxisome proliferator-activated receptor. ©Mayo Foundation for Medical Education and Research. All rights reserved. Journal of Hepatology 2018 69, 275-277DOI: (10.1016/j.jhep.2018.05.012) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions